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The hematological module of the Athlete Biological Passport (ABP) is used in elite
sport for antidoping purposes. Its aim is to better target athletes for testing and to
indirectly detect blood doping. The ABP allows to monitor hematological variations
in athletes using selected primary blood biomarkers [hemoglobin concentration (Hb)
and reticulocyte percentage (Ret%)] with an adaptive Bayesian model to set individual
upper and lower limits. If values fall outside the individual limits, an athlete may be
further targeted and ultimately sanctioned. Since (Hb) varies with plasma volume (PV)
fluctuations, possibly caused by training load changes, we investigated the putative
influence of acute and chronic training load changes on the ABP variables. Monthly blood
samples were collected over one year in 10 male elite cyclists (25.6 ± 3.4 years, 181
± 4 cm, 71.3 ± 4.9 kg, 6.7 ± 0.8 W.kg−1 5-min maximal power output) to calculate
individual ABP profiles and monitor hematological variables. Total hemoglobin mass
(Hbmass) and PV were additionally measured by carbon monoxide rebreathing. Acute
and chronic training loads–respectively 5 and 42 days before sampling–were calculated
considering duration and intensity (training stress score, TSSTM). (Hb) averaged 14.2
± 0.0 (mean ± SD) g.dL−1 (range: 13.3–15.5 g·dl−1) over the study with significant
changes over time (P = 0.004). Hbmass was 1030 ± 87 g (range: 842–1116 g) with no
significant variations over time (P = 0.118), whereas PV was 4309 ± 350mL (range:
3,688–4,751mL) with a time-effect observed over the study time (P = 0.014). Higher
acute–but not chronic—training loads were associated with significantly decreased (Hb)
(P<0.001). Although individual hematological variations were observed, all ABP variables
remained within the individually calculated limits. Our results support that acute training
load variations significantly affect (Hb), likely due to short-term PV fluctuations, underlining
the importance of considering training load when interpreting individual ABP variations
for anti-doping purposes.
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INTRODUCTION
To prevent blood doping in elite cycling, in 2008 the Union
Cycliste Internationale (UCI) spearheaded the introduction of
the Athlete Biological Passport (ABP) (Zorzoli and Rossi, 2010).
The World Anti-Doping Agency (WADA) then progressively
implemented the ABP more widely and currently more than
30,000 blood samples are collected yearly to longitudinally track
various blood markers of athletes (WADA, 2019a). Starting
with average population levels as initial reference, biomarkers
in successive samples from a given athlete allow an individually
expected range to be predicted within which the series of marker
values should fall assuming physiological conditions (WADA,
2019b). This range is calculated with an adaptive Bayesian
statistical model using levels of probability (i.e., specificity)
chosen to estimate the limits of normal physiological variation
(Sottas et al., 2011). The premise is that repeated sampling allows
for a progressive narrowing of the range of values considered
as physiological for a given individual. The adaptive model uses
hemoglobin concentration (Hb) and a stimulation index, the
OFF-score (combining reticulocyte percentage (Ret%) and (Hb)
in g.L−1 with the formula: OFF-Score = (Hb)−60 ×
√
Ret%,
to generate an Atypical Passport Finding (ATPF) if a marker
falls outside the expected range with a 99% specificity (i.e., 1:100
chance or less that this result is due to normal physiological
variation) (WADA, 2019b).
The individualized ranges for the ABP variables need to be
sufficiently large and robustly defined to avoid an ATPF caused
by fluctuations related to factors independent of blood doping
(Sottas et al., 2011). The strict WADA guidelines for blood
collection, transportation and storage prevent misinterpretation
of variations due to such confounders (WADA, 2019b,c,d) while
other physiological confounding factors shall be considered. In
the control process, the athlete fills and signs a doping control
form (DCF) (WADA, 2021) and an ABP supplementary report
form (WADA, 2019a) indicating exercise or competition during
the 2 h prior to the test occasion, medication for the last 7
days, exposure to hypoxia (e.g., altitude sojourn, hypoxic tent)
for the last 15 days or extreme environments (e.g., sauna) for
2 h prior to sampling, whether the sample is being collected
immediately after at least three consecutive days of intense
endurance competition (e.g., cycling stage race), and any blood
donation or loss as a result of an emergency or medical condition
for the past 3 months.
Some markers of the ABP may be influenced by plasma
volume (PV) variations altering their concentration in whole
blood [e.g., (Hb) or hematocrit (Hct)], even though they may
not be sufficient to prove doping (Schmidt et al., 2000). Both
(Hb) or hematocrit Hct, when considered too high, have been
used to apply “No-Start” rules by international federations such
as the International Ski Federation (FIS) and the UCI (Saugy
and Leuenberger, 2020). Exposure to extreme environments (e.g.,
hot or hypoxic) may also alter PV and (Hb) (Sawka et al., 2000;
Stanley et al., 2015; Lobigs et al., 2018a; Young et al., 2019;
Coffman et al., 2020). Further, in competitions over several days
(e.g., elite cycling stage races), variations observed in ABP profiles
were shown to relate to the repeated strenuous exercise and
altitude exposure (Schumacher et al., 2015). Even thoughHbmass
remained stable in cyclists over a 6-day cycling race, unlike Hct
and (Hb) (Garvican et al., 2010), stage racing at altitude was
also reported to induce a hemodilution surpassing any altitude-
induced increase in Hbmass (Garvican-Lewis et al., 2014).
Since such variations alter the ABP profiles (Gough et al.,
2013) these confounders shall be reported in the DCF and ABP
supplementary report forms (WADA, 2016) to allow for an
informed evaluation of the ABP.
In response to a call for inclusion of “all other relevant
information also comprising training and competition results”
(Vernec, 2014), monitoring athletic performance (and hence
training content) has been proposed (Faiss et al., 2019), to
further strengthen the ABP and its interpretation. Hematological
biomarkers vary during a competitive season in athletes among
disciplines (Banfi et al., 2006, 2011; Diaz et al., 2011; Andelkovic
et al., 2015). This could be due to plasma volume variations
induced by effort in competition vs. out of competition
(Morkeberg et al., 2009), or strength and endurance training
periods (Collins et al., 1986; Imelik and Mustimets, 1992; Sawka
et al., 2000). Little is known about any direct influence of training
load variation (i.e., calculated during training and when power
data in competitions are available) on hematological variables
(Guglielmini et al., 1989; Varamenti et al., 2018). There are no
studies investigating the influence of training load (including
competitions) over a prolonged period on the ABP variables in
elite cyclists.
The purpose of this study was therefore to monitor training
load in elite cyclists over one year and analyze if and how
individual ABP profiles constructed frommonthly blood samples
vary with training load. To further address the within-subject
variance of (Hb) (Lobigs et al., 2016; Garvican-Lewis et al.,
2020), we also determined PV and Hbmass indirectly to assess
whether changes due to environmental conditions (e.g., effect
of season) or prolonged periods of high vs. low-training loads
alter PV and Hbmass to an extent affecting ABP profiles. We
hypothesized that acute (5 days) and chronic (42 days) training
fluctuations before an ABP sample would notably change the




Tenmale elite cyclists (25.6± 3.4 years, 181± 4 cm, 71.3± 4.9 kg,
6.7 ± 0.8 W.kg−1 5-min maximal power output) volunteered to
participate in the study. All were members of the Swiss national
cycling team or an elite cycling team registered at Swiss Cycling,
and competing in road, track, and mountain-bike cycling events
at an international level (e.g., UCI World and Europe Tour
races or UCI World Cups). Initially, 12 subjects were recruited.
One subject withdrew due to personal reasons. Another subject
was excluded because of a medical condition during the study
affecting his hematological variables, precluding the training load
from being considered as the major factor of any variation in
the hematological variables. Subjects all lived < 800m and were
healthy. No iron supplementation was used for the duration
Frontiers in Sports and Active Living | www.frontiersin.org 2 March 2021 | Volume 3 | Article 618285
Astolfi et al. Athlete Biological Passport & Training Load
of the study. Prolonged exposures to hypoxic environments
(>6 h at an inspired O2 pressure <120 mmHg) were entered
into the training diaries. Among the 10 cyclists only two were
exposed to prolonged hypoxic stimuli with a possible effect on
erythropoiesis. Cyclist 6 spent 27 days at an average altitude of
2,750m during a vacation in Peru during which training load
was drastically reduced (see Figure 3). This resulted in a large
increase in Ret%with no influence of training load for the highest
value in this specific case. Cyclist 7 slept in a hypoxic tent for 36
nights with an average daily exposure of 9 h at a simulated altitude
progressively increased from 2,500 to 3,500m (see Figure 4)
with a concomitant rapid increase in Ret% and delayed increase
in Hbmass.
All participants provided a fully informed written consent to
participate after the procedures and risks were explained. The
study protocol was approved by the regional research ethics
committee (CER-VD, Lausanne, Switzerland, #2018-01019) and
conducted in respect of the Declaration of Helsinki.
Blood Sampling and Analysis
Venous blood samples were collected once monthly from every
participant by the same experienced phlebotomist. Due to
competition schedules and training camps, the samples were
separated by 32± 12 days. Venipuncture was realized with a 21G
short manifold butterfly needle inserted into an antecubital vein
(Sarstedt Safety-Multifly R©, Sarstedt AG, Nümbrecht, Germany).
WADA blood collection guidelines were strictly followed with
no physical exercise allowed in the 120min preceding sampling
and blood collection done after 10min in a seated position, with
the exception that instead of the recommended BD Vacutainer R©
tubes (K2-EDTA CE cat no 368856/ref US 367856) we collected
blood in Sarstedt S-Monovette tubes (K2 EDTA 2.7mL, Sarstedt
AG, Nümbrecht, Germany), which we considered equivalent.
(WADA, 2016, 2019b). Samples were stored at 4◦C for 30min
to 12 h after collection before analysis, depending on instrument
and technician availability. Samples were homogenized at room
temperature (21◦C) on a roller system for 15–45min before
analysis with a fully automated flow cytometer (Sysmex XN1000,
Sysmex Europe GmbH, Norderstedt, Germany). Three internal
quality controls provided by the manufacturer (Sysmex XN-
Checks, levels 1, 2, and 3) were run two times before each
batch of samples. The analysis was repeated to produce two
successive analyses with differences ≤ 0.1 g.dL−1 for (Hb),
and 0.15 or 0.25% for Ret% (depending on whether Ret%
was inferior or superior to 1%) conforming to the applicable
WADA guidelines (WADA, 2019b). The first valid test result was
then recorded. The stimulation index OFF-score was calculated
as [(Hb) × 10] − 60 ×
√
Ret% and the Abnormal Blood
Profile Score (ABPS) was calculated combining Ret%, (Hb),
hematocrit (HCT), red blood cell number (RBC#), mean red cell
volume (MCV), mean red cell Hb (MCH), and mean cell Hb
concentration (MCHC) using the mathematical algorithms in
WADA’s Anti-Doping Administration and Management System
(ADAMS) (WADA, 2019c).
Individual ABP Profiles
For each participant an individual longitudinal ABP profile was
constructed with the values obtained from the collected blood
samples using the official ABP-module in WADA’s ADAMS
Training Software entering data from each sample individually.
The system calculates ABPS and OFF-score for each sample
and then generates individual ABP profiles with (Hb) and
OFF-score as primary markers and Ret% and the ABPS as
secondary ones. Population-based upper and lower limits are
used for the first blood sample after which an adaptive model
generates individually varying limits for each subsequent blood
sample considering the individual’s previous analytical results.
An Atypical Passport Finding (ATPF) is generated when (a) the
(Hb) and/or OFF-score value of the last entered sample falls
outside the lower and upper intra-individual limits or (b) when
the last 2–5 (Hb) and/or OFF-score values deviate from the
expected range (a so-called “sequence ATPF”). For the first case,
the applied specificity is 99% (i.e., 1:100 chance or less that the
deviation is due to normal physiological variation). For the latter,
the applied specificity is 99.9% (i.e., 1:1,000 chance or less that
the sequence deviation is due to normal physiological variation).
An ATPF results in a notification to the Athlete Passport
Management Unit (APMU) handling the administration of the
individual passport on behalf of a passport custodian. The
APMU may request expert opinions and declare an adverse
passport finding (APF) after three independent experts with all
available information (i.e., whereabouts information, calendar
competitions, altitude sojourns/exposures) unanimously deemed
the profile likely to result from doping. An APMU may also
request an expert opinion in the absence of an ATPF when
unusual variations (e.g., compatible with artificial hemodilution)
are observed in ABP profiles even though remaining within
individual limits. This may lead to a stronger surveillance of the
athlete with increased and targeted doping controls.
To complement the analysis of variations in ABP variables, for
(Hb) and the OFF-score, we also calculated the shortest absolute
distance to the closest individual limit (i.e., from the upper or the
lower limit).
Total Hemoglobin Mass and Plasma
Volume
Hbmass was determined monthly over the last eight months of
the study, with a fully automated blood volume analyzer (OpCo:
Detalo Instruments, Birkerod, Denmark) based on a carbon
monoxide (CO) rebreathing technique, as described elsewhere
(Siebenmann et al., 2017). For logistical and time constraints,
data collection had to start before the blood volume analyzer
was made available so that Hbmass data is missing for the four
first months of the study. Briefly, participants were comfortably
installed in supine position with a nose clip and a mouthpiece
connected to a closed rebreathing circuit. They then breathed
100% oxygen (O2) for 4min to flush the airways of nitrogen.
Subsequently, a bolus of 1.5 mL/kg of 99.997% chemically
pure CO (Carbagas, Liebefeld, Switzerland) was introduced into
the circuit after which the participants rebreathed the O2-CO
mixture for 9min. Rebreathing was done in supine condition to
improve CO mixing (Keiser et al., 2013); 9min were reported
sufficient to observe a peak in venous carboxyhemoglobin
content (HbCO%). Venous blood was drawn from an antecubital
vein and immediately analyzed in triplicate for HbCO% with a
calibrated gasometer (ABL80-Co-Ox, Radiometer, Copenhagen,
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Denmark). Initial duplicate measurements in our laboratory
yielded a typical error (TE) of 1.8% for Hbmass, in line with
previously reported values (Siebenmann et al., 2017; Rønnestad
et al., 2020). The CO remaining in the system was measured
with a CO meter (Monoxor Plus, Bacharach, New Kensington,
USA) and subtracted from the initial amount introduced to
define the exact CO bolus received with a 0.1mL typical error.
Hbmass was calculated from the difference inHbCO%before and
after CO-rebreathing with the following formulas proposed by
Siebenman et al., (2017):1HbCOwas calculated as the difference
in %HbCO (i.e. pre- and post-rebreathing). The fraction of
unabsorbed CO was measured with the aforementioned CO
meter in the rebreathing circuit to determine the exact volume
of CO effectively absorbed by the subject (VCOabsorbed in liters).
nCOabsorbed was calculated in moles (based on the ideal gas law)
as nCOabsorbed = Patm × VCOabsorbed/(R × T), where R is the
ideal gas constant [0.08206 L atm/(mol·K)]; Patm, the ambient
pressure in atmosphere; and T the temperature in Kelvin. Since
one molecule of hemoglobin binds four molecules of CO, the
amount of Hb bound with CO can be calculated in moles as
nHbtagged = nCOabsorbed/4.
The dilution principle then allows to calculate nHbtotal =
(nHbtagged/1HbCO) × 100%; and finally, Hbmass (in grams)
was calculated with the molar mass of hemoglobin as: Hbmass
= nHbtotal × 6.44× 104 (Siebenmann et al., 2017).
Training Load Quantification
Participants were instructed to follow their habitual training and
competition schedules as planned with their personal trainer
and to report all their training and competition activities in
a commercially available online training monitoring interface
[Training PeaksTM (TP), PeaksWare, Lafayette, CO, USA].
Since all participants were already using TP to monitor their
training, we could collect training data for the 42 days prior
to the first blood sampling in addition to the 12 months of
the monitoring of their hematological variables. All used a
crank-based power meter (SRM, Schoberer Rad Messtechnik,
Juelich, Germany) for their cycling-based training sessions
allowing their training load to be accurately quantified as
a function of the duration and intensity of each training
session. Since the bicycles of the participants were equipped
with power meters, the load from races and competitions was
included in the calculation of the overall training load. They
were instructed to proceed to regular static calibration and
zero-offset calibrations of their power meter according to the
manufacturers’ recommendations.
The Training Stress Score (TSSTM, arbitrary units) was
selected in this study to quantify training load because it was
reported to be very reliable in competitive cyclists providing
a strong dose-response relationship for the changes in aerobic
fitness (Sanders et al., 2017). TSS was automatically calculated
for each training session in TP using the following formula:
TSS (a.u.) = [(t × NP × IF)/(FTP × 3,600)] × 100 where
t is the duration in seconds, FTP represents the functional
threshold power calculated as 95% of the average power from
a recent 20-min steady-state all-out time trial or maximal
effort, NP is the normalized power, representing a calculation
of the power that could have been maintained for the
same physiological “cost” if the power had been perfectly
constant, and IF is the intensity factor indicating the relative
intensity of the session calculated as the ratio of NP to
FTP (Coggan, 2019).
Individual FTP values were determined at the beginning of the
study based on the results of a maximal 20-min field or laboratory
test realized under supervision of their personal trainer. The
initially calculated FTP value was not modified during the study
to allow for an adequate comparison of training loads and their
variation throughout the study.
Acute training load (ATL) was calculated as the load during
the 5 days preceding each monthly blood sample both as a score
cumulating and averaging the TSS over 5 days. Chronic training
load (CTL) was defined as the load for the 42 days (6 weeks)
preceding blood sampling and calculated again as a cumulated
TSS over the period.
Training loads for High vs. Low training load periods for
each cyclist were obtained by identifying the periods with the
highest and lowest 12-week cumulative TSS. Seasonal training
variation (Winter vs. Summer) was quantified calculating the
cumulated TSS during three winter months (December, January,
and February) and three summer months (June, July, and
August), respectively.
Statistical Analyses
Values are reported as means and standard deviations. The range
reports the maximum and minimum from the individual values
to describe data dispersion. Using data from 12 monthly blood
samples for each participant (cluster variables, random factor),
repeated measures analyses were conducted for each of the four
primary variables of the ABP [i.e., (Hb), Ret%, OFF-score and
ABPS] with a mixed model to determine whether changes in
the dependent variables (ABP variables) differed over time (fixed
factor). This technique was preferred to a repeated measures
ANOVA because it also allows to handle dynamic predictors. The
effect on the ABP variables, Hbmass, and plasma volume of Acute
or Chronic training load, seasonal variations in training load as
well as periods withHigh vs. Low training load were assessed with
mixed models using training load as time-dependent covariate.
To indicate the effect of an independent variable, the value of
the statistic with its degrees of freedom and the P value of
the test are presented in parenthesis. In case of a quantitative
independent variable (a covariate), the estimate of the parameter
associated to it is presented in addition. Visual inspection of
residual plots allowed excluding any obvious deviations from
homoscedasticity or normality. Polynomial contrasts were used
for time inmixedmodels, employing the Bonferronimethod. The
Pearson correlation coefficient was calculated for the relationship
between individual PV and (Hb) variations (calculated in %).
The level of significance was set at P < 0.05. All statistical
analyses were conducted with an open source dedicated statistical
software (Jamovi, Jamovi Project Software, retrieved from https://
www.jamovi.org).
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RESULTS
Hematological Variations Over 12 Months
(Hb) averaged 14.2 ± 0.1 g·dl−1 (range: 13.3–15.5 g.dL−1) over
the study, while the ABPS averaged −1.32 ± 0.41 a.u. (range:
−1.68 to −0.40 a.u.), both with significant variations over the 12
months [(Hb) (F (11, 99) = 2.76, P = 0.004] and ABPS [F (11,
99) = 3.54, P < 0.001]. Ret% averaged 1.2 ± 0.31% (range: 0.76–
1.81%) and the OFF-score 76.6± 10.0 a.u. (range: 64.0–91.7 a.u.)
with no significant variation over the study time [Ret% (F (11, 99)
= 1.85, P = 0.056] and OFF-score [F (11, 99)= 1.77, P = 0.069].
Average hematological values over the 12 months for each cyclist
are presented in Table 1.
Hbmass averaged 1,030 ± 87 g (range: 842–1,116 g) with no
significant variation over the study time [F (7, 52) = 1.75, P =
0.118]. Conversely, a significant time effect was observed for PV
[F (7, 52) = 2.83, P = 0.014] which averaged 4,309 ± 350mL
(range 3,688–4,751 mL).
Within-Subject Variations
The measured variables in the ABP profiles remained within
the individualized limits; and no ATPFs were outlined. The
distance to the individual limits for (Hb) and OFF-score values
yielded an average mean lowest distance to the limits of 1.0
± 0.4 g·dL−1, and 18.5 ± 3.9 (a.u.), respectively. Over the 120
measurements (10 subjects × 12 blood samples), 10 (Hb) values
(8.3%) fell within a distance to the (upper or lower) individual
limit < 0.5 g·dl−1 and 4 within a < 0.1 g·dl−1 (3.3%) distance.
Four individually calculated OFF-score values were closer than 5
points (a.u.) to an individual limit (3.3%).
A significant negative correlation between PV variations (in
%) and (Hb) variations (r =−0.46, P < 0.001) was found.
Three illustrative examples of individual ABP profiles are
presented in Figures 2–4; and the hematological profiles of the
remaining cyclists are available as Supplementary Files.
Training Load Analysis
The average cumulated TSS over 12 months amounted to 29,128
± 10,091 a.u. For the High load period average cumulated TSS
amounted to 10,389 ± 2,933 a.u. vs. 3,440 ± 2,544 a.u. during
the Low load period. Cumulated TSS during the Low load
period represented on average 31 ± 18% of the High Load
TSS. The average cumulated Winter TSS was 7,396 ± 2,817 a.u.,
representing on average to 89 ± 50% of the Summer TSS [(7,609
± 3,658 a.u.) P = 0.75] (Table 2). Cumulated TSS was 353 ±
292 a.u., and 3,310 ± 1,466 a.u. over the 5 (ATL) and 42 days
(CTL) preceding blood sampling, respectively. Both ATL and
CTL varied significantly with time (P = 0.002 for ATL and P <
0.001 for CTL) (Figure 1 and Table 1).
Seasonal and Training Load Period
Influence on the ABP
Training load period (High load vs. Low load) did not
significantly affect ABP variables [i.e., (Hb) (P= 0.50), OFF-score
(P = 0.49), Ret% (P = 0.16), ABPS (P = 0.29)] or Hbmass (P
= 0.36) and PV (P = 0.86). There was no significant effect of
season on the ABP variables (i.e., (Hb) (P = 0.87), OFF-score (P
= 0.96), Ret% (P = 0.87), ABPS (P = 0.20) and on Hbmass (P =
0.45) and PV (P = 0.06). Hematological variations with respect
to High vs. Low training load periods andWinter vs. Summer are
summarized in Table 2.
Influence of Acute and Chronic Training
Load on the ABP Variables
There was a significant effect of cumulated TSS over the five days
preceding blood sampling (ATL), on (Hb) [F (1,102)= 12.8, P <
0.001], b=−0.0036, and PV [F (1,55)= 7.76, P= 0.007, b= 2.2,
(indicating that a higher ATL was associated with a lower (Hb)],
but not ABPS [(F (1,102) = 3.35, P = 0.07], OFF-score [(F (1,
102) = 3.77, P = 0.055], Ret % [(F (1, 102) = 1.18, P = 0.28] or
Hbmass [F (1, 52)= 2.05, P = 0.16].
No significant effect of CTL was observed neither on the ABP
variables norHbmass and PV [(Hb) (F (1,106)= 1.86, P= 0.176],
Ret% [F (1,106) = 1.62, P = 0.2], OFF-score [F (1, 106) = 0.016,
P= 0.89], ABPS [F (1, 106)= 2.34, P= 0.129], Hbmass [F (1,55)
= 1.72, P = 0.195], PV [F (1, 57) = 0.85, P = 0.36]. For each
cyclist, ATL, CTL, and total training load over the 12 months are
reported in Table 1.
DISCUSSION
By collecting and analyzing monthly blood samples together with
training stress score in a cohort of elite cyclists over a 1-year
period, we could test the hypothesis that variations in training
load over time lead to relevant changes in ABP parameters. The
main finding of this study was that acute changes in training
load (5 days) prior to blood sampling influenced ABP parameters
[e.g., (Hb)], via changes in plasma volume. Chronic changes in
training load (42 days) did not influence the ABP parameters.
We observed significant variations in PV (but not Hbmass) over
time. Despite the highlighted variations ABP variables remained
within the individual limits at all times.
Endurance athletes reportedly have greater PV in comparison
with team sports athletes, power endurance athletes, and disabled
or untrained subjects (Fellmann, 1992). Endurance athletes
also have fluctuations in PV, potentially inducing variations in
biological markers that are concentration sensitive such as (Hb)
(Lobigs et al., 2016). In agreement we found (Hb) and PV
to significantly vary over a 1-year period, while Hbmass did
not. The significant correlation we observed between individual
variations of PV and (Hb) (r = −0.46, p < 0.001) indicates that
PV monitoring would allow to better interpret (Hb) alterations.
Nevertheless, while 21% of the variance in the (Hb) variations
may be explained by PV changes, measuring PV (and Hbmass)
by CO-rebreathing (even with a minimal dose) is actually not
possible as part of the doping control for technical and ethical
reasons. Serum markers of PV variations do in this context
present an elegant alternative that could be included in future
research monitoring hematological variations longitudinally
(Lobigs et al., 2018b). This model was recently used on 29
elite cyclists to address the influence of PV variations on
concentration-based biomarkers (Garvican-Lewis et al., 2020).
Variations in environmental temperature may also affect blood
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TABLE 1 | Average individual hematological variables and training load over 12 months.
(Hb) g/dl OFF-score a.u. Ret % ABPS a.u. Hbmass* g PV* mL ATL a.u. CTL a.u. Total TSS a.u.
Cyclist 1 14.4 ± 0.4 91.7 ± 4.7 0.76 ± 0.1 −1.47 ± 0.2 1,021 ± 45 4,222 ± 225 317 ± 276 1,572 ± 986 18,871
Cyclist 2 13.5 ± 0.8 72.9 ± 8.3 1.07 ± 0.2 −1.68 ± 0.3 1,021 ± 51 4,703 ± 491 243 ± 252 2,234 ± 1,122 26,814
Cyclist 3 13.8 ± 0.5 65.3 ± 6.5 1.49 ± 0.2 −1.59 ± 0.3 1,045 ± 28 4751 ± 185 256 ± 276 1,872 ± 1,244 22,466
Cyclist 4 15.5 ± 0.6 86.9 ± 5.8 1.31 ± 0.2 −0.40 ± 0.5 1,157 ± 24 3,998 ± 641 110 ± 193 1,395 ± 1,146 16,751
Cyclist 5 14.8 ± 0.4 85.2 ± 4.4 1.08 ± 0.2 −0.91 ± 0.5 1014 ± 33 3,944 ± 374 524 ± 319 2,579 ± 1,314 30,957
Cyclist 6 13.3 ± 0.6 64.4 ± 11.0 1.32 ± 0.4 −1.59 ± 0.2 950 ± 35 4,318 ± 377 583 ± 273 4,004 ± 1,079 48,050
Cyclist 7 13.4 ± 0.4 80.3 ± 5.7 0.8 ± 0.2 −1.58 ± 0.1 842 ± 17 3,688 ± 208 237 ± 179 1,619 ± 876 19,439
Cyclist 8 14.3 ± 0.6 74.1 ± 7.0 1.32 ± 0.2 −1.55 ± 0.3 1,116 ± 21 4,637 ± 338 357 ± 285 3,174 ± 1,584 38,090
Cyclist 9 14.2 ± 0.5 80.9 ± 5.5 1.05 ± 0.1 −1.52 ± 0.4 1,079 ± 18 4,417 ± 286 517 ± 236 2,768 ± 829 33,223
Cyclist 10 14.4 ± 0.6 64.0 ± 5.7 1.81 ± 0.3 −1.04 ± 0.5 1,056 ± 33 4,421 ± 309 387 ± 324 3,051 ± 968 36,620
Mean 14.2 ± 0.01 76.6 ± 10.0 1.2 ± 0.31 −1.32 ± 0.41 1,030 ± 87 4,309 ± 350 307 ± 118 2,427 ± 840 29,128 ± 10,091
Values reported as means ± SD. (Hb), hemoglobin concentration; OFF-score; Ret%: reticulocytes percentage; ABPS, abnormal blood profile score; Hbmass, total hemoglobin mass;
PV, plasma volume; along with acute training load (5 days, ATL), chronic training load (42 days, CTL) before blood sampling and total training stress score (TSS) over one year; a.u.,
arbitrary units. *Hbmass and PV were monitored during the last eight months of the study.
TABLE 2 | Average hematological variables according to season and to training load.
Summer Winter Change (%) High load Low load Change (%)
(Hb) (g/dl) 14.1 ± 0.8 14.2 ± 0.7 0.7 14.0 ± 0.6 14.4 ± 1.0 2.8
Off-score (a.u.) 76.8 ± 10.0 78.8 ± 11.1 2.6 77.1 ± 9.3 77.6 ± 11.9 0.6
Ret% 1.18 ± 0.3 1.15 ± 0.3 −2.5 1.1 ± 0.3 1.3 ± 0.3 18.2
ABPS (a.u.) −1.42 ± 0.5 −1.25 ± 0.4 12.0 −1.44 ± 0.4 −1.23 ± 0.6 14.5
Hbmass (g)* 1,032 ± 84 1,023 ± 86 0.9 1,048 ± 99 1,079 ± 41 3.0
PV (mL)* 4,442 ± 403 4,148 ± 393 −6.6 4,399 ± 354 4,342 ± 502 −1.3
TSS (a.u.) 7,609 ±3,658 7,396 ± 2,817 −2.8 10,389 ± 2,933** 3,440 ± 2,544 −67
Data are presented as means ± SD. (Hb), hemoglobin concentration; OFF-score, Ret%, reticulocytes percentage; ABPS, abnormal blood profile score; Hbmass, total hemoglobin
mass; PV, plasma volume; a.u., arbitrary units. Summer vs. winter were calculated as the cumulated TSS over three months, high vs. low training loads are calculated as the maximal
and minimal cumulated TSS per months over three successive months. *Hbmass and PV were monitored during the last eight months of the study. **P < 0.001 for the difference with
Low load (TSS).
variables and circulating volumes (Doupe et al., 1957; Sawka
et al., 1987). We found for instance that a training period in
warm summer months was associated with a 4.7% increase in
PV, although not significant, (when compared to winter) even
though ABP variables or Hbmass were not influenced. The
seasonal discrepancies in PV were not clearly associated with
training in our study, although they were in line with the above-
mentioned literature considering winter vs. summer temperature
in Switzerland where the study was conducted (Table 2).
Our study allowed to contrast the influence of acute (5 days,
ATL) variations of training load with the load considered over
a longer time (42 days, CTL) before each blood sample. We
found that higher ATL was accompanied by lower (Hb) and
increased PV. This strongly suggests a hemodilution associated
with short-term ATL fluctuations as reported in the literature
with PV increase after an acute increase in training load (at the
start of an exercise training program) (Sawka et al., 2000; Bejder
et al., 2017; Garvican-Lewis et al., 2020).
An acute hemodilution was recently observed in professional
floorball players immediately after a game [>3% decrease in
(Hb)] while values returned to baseline after 2-h (Wedin and
Henriksson, 2020). In an anti-doping context, the pre-analytical
bias possibly due to the acute effect of one single strenuous effort
is avoided with the compulsory 2-h waiting time after the exercise
before blood sampling is allowed (WADA, 2019c). The latter
rule does however not apply to repeated exercises (i.e., training
load) on the days before a blood sample. Our results therefore
suggest that monitoring or at least reporting the training load
for several days before blood sampling, in addition to the days
of competition reported in the DCF, would reasonably allow a
better interpretation of ABP variables in an anti-doping setting.
Phases with possibly lower training loads (e.g., holidays or off-
season periods, taper periods) are expected to have an influence
on blood variables (Mujika et al., 2000), while this influence
would also certainly be altered in sporting disciplines requiring
training loads (in terms of both volume and intensities) differing
from those in cycling.
In our cohort of elite cyclists, we identified prolonged 3-
months periods with significantly higher training loads, but
these did not have a significant effect on the variation of ABP
profiles (Table 2). Conversely, (Hb) was shown to decrease
in a workload dependent manner while red blood cell count
remained constant in 19 elite competitive soccer players over
half a competitive season of 3 months with a controlled training
program (Andelkovic et al., 2015). This underlines the prime
relevance of within-subject variation and the influence of sport
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FIGURE 1 | Average 12 months representation of (A) (Hb): hemoglobin
concentration; (B) Hbmass: total hemoglobin mass; (C) PV: plasma volume;
along with (D) training load (a.u.) (cumulated daily TSS) with acute training load
(5 days, ATL) and chronic training load (42 days, CTL) before sampling; a.u.:
arbitrary units. P–values for the statistical difference over the 12 months.
discipline training load specificity in the ABP that needs to be
considered on an individual basis, despite the scientific relevance
of cohort results.
The ABP was hence designed to allow “switching the focus
from comparison with a population to the determination of
individual values” (Sottas et al., 2010). Bayesian networks
were used for the ABP, because they allow to represent the
causal relationship between blood doping and its effect on
hematological biomarkers (Koski and Noble, 2009; Kruschke,
2011). For instance, if blood doping [e.g., recombinant human
erythropoietin (rhEPO) use] leads to an increased (Hb), rhEPO is
the cause and a higher (Hb) the effect. Monitoring hematological
biomarkers in a longitudinal profile is thus challenging because it
goes against the causal direction. The way the ABP was designed
allows however to analyse the probability that hematological
variations may be due to doping rather than natural fluctuation
based on existing data showing reference ranges and within-
subject variability of either doped or non-doped populations
(Malcovati et al., 2003). Individual limits for each biomarker of
the ABP are set with a high specificity (e.g., 99%) characterizing
the proportion of negative (not being doped) correctly identified.
In other words, this means that there is less than 1:100 chance
that a value outside of the limits is due to a normal physiological
condition. The advantage of Bayesian networks is that they allow
to include heterogeneous and confounding factors (e.g., age, sex,
ethnic origin, type of sport, altitude exposure) (Sottas et al.,
2010). Already when it was launched, the potential of the ABP in
integrating new potential confounding factors (i.e., training load)
into the Bayesian adaptive model was acknowledged (Sottas et al.,
2011). Now the inclusion of performance models has also been
proposed (Faiss et al., 2019).
In our study, to complement the ABP approach, we addressed
within-subject variance, and the influence of PV variations by
looking at the lowest distance to the individual limits calculated
by the Bayesian model for each successive sample. For example,
we observed three successive (Hb) values within 0.1 g·dL− to the
individual limit with a concomitant increase in PV of 1,344mL
in one cyclist (Figure 2). However, when considering all 10 elite
cyclists (120 ABP points over one year) and despite noticeable
differences in PV or (Hb), no ATPFs were observed, with the
lowest distance to the individualized upper and lower limits
for (Hb) falling only 10 times < 0.5 g·dL−1. The inspection
of individual ABPs however did not reveal a single pattern
in the cyclists population regarding how the training load
may potentially alter blood values. The visual inspection of
individual variations (Figures 2–4) allows to illustrate some
patterns of variation observed in training load, and hematological
variables. The variations were not uniform and individual
interpretation of within-subject variance in the context of the
APB is paramount: a decrease in (Hb) may result from a
large increase in PV (over 1,200mL), likely related to increased
training load while the concomitant increase in Hbmass is less
pronounced (see example in Figure 2). Alternatively, changes
in training load may not necessarily result in concomitant
fluctuations in (Hb) (see example in Figure 3). Finally, a rather
stable ABP profile may appear despite high variations in PV (+
18%) and Hbmass (+ 6%) (see Figure 4). The latter example
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FIGURE 2 | Representations of the Athlete Biological Passport (ABP) hematological profile for cyclist 2 with (A) (Hb): hemoglobin concentration; (B) OFF-score, (C)
Ret%: reticulocytes percentage; (D) ABPS: abnormal blood profile score; over the 12 months of the study design. Solid lines represent the athlete’s values, dotted
lines represent the upper limits and lower limits calculated by an adaptive Bayesian model (see methods section for details). (E) Triangles figure total hemoglobin
mass (g) and circles represent plasma volume (mL) over the last eight months of the study; (F) Acute training load (ATL) and chronic training load (CTL) represent the
load respectively 5 and 42 days before sampling. Vertical grey bars represent hypoxic exposure. ABP profile for cyclist 2 showing a prolonged state near the individual
limits calculated for (Hb). (Hb) decreased from December to June by 17.6% however, an increase in Hbmass of 3% between January and June was observed with an
increase of 28% of PV (4,461–5,719mL) despite a decrease in chronic training load of −65% from January to August.
would additionally question the usefulness of including training
content in the interpretation of a profile with no noticeable
(Hb) variation notwithstanding significant changes in training
load. To summarize, despite statistically significant relations
obtained on aggregate data, there was no systematic association
between PV, Hbmass, and individually interpreted ABP variables.
Overall, our results are the first, to our knowledge, suggesting that
the current individual limits of the ABP seem sufficiently robust
to prevent a falsely negative interpretation of an ABP profile even
though training load variations are present.
Bearing this in mind, blood doping remains attractive to
augment Hbmass and improve convective oxygen transport
capacity (Warburton et al., 2000) even with low-volume
transfusions that can have a significant performance enhancing
effect (Bejder et al., 2019). In a laboratory setting, minimal
changes in Hbmass, as low as 1 g.kg−1, can be accompanied by
a significant change in aerobic capacity (Schmidt and Prommer,
2010). To that extent we confirmed the previously reported link
between absolute Hbmass and aerobic capacity in elite cyclists
(Garvican et al., 2011; Hauser et al., 2017). It could therefore
be argued that Hbmass would be a valid marker to complement
the ABP analysis. The lack of relative influence of Hbmass (in
g.kg−1 bodyweight) on time-trial performance may support the
effect of a higher PV to reduce peripheral resistance to improve
oxygen delivery to the muscle (Warburton et al., 2000; Mairbäurl,
2013). The relative weight of variations in single biomarkers in
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FIGURE 3 | Representations of the Athlete Biological Passport (ABP) hematological profile for cyclist 6 with (A) (Hb): hemoglobin concentration; (B) OFF-score, (C)
Ret%: reticulocytes percentage; (D) ABPS: abnormal blood profile score; over the 12 months of the study design. Solid lines represent the athlete’s values, dotted
lines represent the upper limits and lower limits calculated by an adaptive Bayesian model (see methods section for details). (E) Triangles figure total hemoglobin
mass (g) and circles represent plasma volume (mL) over the last eight months of the study; (F) Acute training load (ATL) and chronic training load (CTL) represent the
load respectively 5 and 42 days before sampling. Vertical grey bars represent hypoxic exposure. ABP profile for cyclist 6 showing a high variability in hematological
parameters, especially for (Hb). Mean (Hb) was 13.5 ± 0.77 g.dL–1 for this cyclist with the highest SD among all the cyclists with values ranging from 12.2 to 14.4
g.dL–1 t (variation of 16%). Values close to the limits are also encountered for the OFF-score and Ret%. This cyclist went on holidays for 4 weeks at an average
altitude of 2,750m in Peru before sample 3 (October). The hypoxic dose amounted to 1,782 km.h–1 calculated according to (Garvican-Lewis et al., 2016) explaining
the increased Ret% value. Besides, Hbmass varied only by 2% between February until August (945–963g) and only 3% variations in PV for the same period
(3,979–4,129mL). Despite high variations in the ABP biomarkers, chronic training load did not significantly vary for this cyclist from January to August (+15%).
influencing the ABP markers should therefore be interpreted
with care. This underlines the key role of ABP experts for a
qualitative interpretation of suspicious profiles by accounting for
and discriminating all possible confounders properly.
Strengths and Limitations
The strength of this study is that our cohort was composed
exclusively of highly-trained elite cyclists and the first one
collecting and interpreting monthly blood samples together
with quantification of Hbmass and training load over 12
months. Half of the participating athletes were part of a
registered testing pool and subject to anti-doping testing and
ABP profiling. Our findings may thus adequately reflect the
situation found in an anti-doping context analyzing ABP profiles
of elite athletes. With an informed consent to participate
in the project, it can be reasonably assumed (but not fully
excluded) that the cyclists did not commit any anti-doping
rule violation during the study. We must however acknowledge
our small sample size limiting the power of our inferential
analyses and Hbmass missing values for the first months of
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FIGURE 4 | Representations of the Athlete Biological Passport (ABP) hematological profile for cyclist 7 with (A) (Hb): hemoglobin concentration; (B) OFF-score, (C)
Ret%: reticulocytes percentage; (D) ABPS: abnormal blood profile score; over the 12 months of the study design. Solid lines represent the athlete’s values, dotted
lines represent the upper limits and lower limits calculated by an adaptive Bayesian model (see methods section for details). (E) Triangles figure total hemoglobin
mass (g) and circles represent plasma volume (mL) over the last eight months of the study; (F) Acute training load (ATL) and chronic training load (CTL) represent the
load respectively 5 and 42 days before sampling. Vertical grey bars represent hypoxic exposure. ABP profile for cyclist 7 showing few variations. (Hb) varied from 12.8
to 14.4 (10%) with a 6% Hbmass variation (819–870 g) despite a 18% change in PV (3,413–4,012mL) and a chronic training load increase of 83% from January to
August. Cyclist 7 slept in a hypoxic tent for 36 nights with an average daily exposure of 9 h at an inspired oxygen pressure of 14.8% (simulating 2,500m). The hypoxic
dose amounted to 972 km.h–1 calculated according to Garvican-Lewis et al. (2014) with 459 km.h–1 and 513 km.h–1 before after and measurement 11, respectively,
explaining the sustained high Ret% with a delayed 3% Hbmass increase between measurement 11 and 12.
the study due to technical issues with the device. In addition,
our study cohort only included male cyclists; variations due
to menstrual cycles in women (Mullen et al., 2020) would
need to be considered to further extend our observations.
Besides, even with strict measurement procedures for Hbmass
yielding an acceptable typical error of measurement, it cannot
be excluded that a bias occurred in very few individual
measurements for the determination of COHb fraction if
a certain degree of hemolysis had occurred in the venous
sample collected (Lippi et al., 2013). Each single measurement
was carefully verified, but this may however have resulted
in artificially high Hbmass with no other confounder clearly
identified (e.g., Figure 2, June). Even though unidentified
confounders other than exercise training may have influenced
certain variables in single measurements, we feel confident
that this does not alter the overall conclusion from our
inferential perspective.
In addition, the quantification of training load is notoriously
difficult. Arguably our approach using TSS (combining intensity
from power output and volume with training duration) was
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deemed the most pertinent when designing the study, with an
interface routinely used by all our cyclists and their trainers. We
decided to maintain the same FTP for each athlete during the
study time as it is often the case in real setting, however we
must admit that this choice might have affected the training load.
Characterizing objectively short periods of high acute training
load before a blood test definitely remains challenging with the
numerous training strategies possible. A simple declaration of
high ATL (as a pretended alternative to blood withdrawal) may
not be considered ultimately by an ABP expert as a unique
pertinent explanation for a drop in (Hb). Nevertheless, based
on our findings we see a rationale for the inclusion of more
complete information on training load on the days preceding
an ABP sampling procedure. While athletes would obviously
not agree to share training “secrets,” adding a simple question
to the doping control forms on training volume and intensity
during the days preceding a test could represent a first step
toward a more transparent and meaningful interpretation of
ABP profiles.
In conclusion, we consider the ABP as a powerful tool for
targeting anti-doping tests, and indirect detection of doping.
Our study suggests that variations of acute training load (i.e.,
the 5 days before a sample is collected) may influence the
ABP readings. Considering specific confounding factors (i.e.,
training load) is therefore certainly paramount in the qualitative
assessment of variations observed in ABP profiles to adequately
aim for cost-effective testing plans targeting the right athletes at
the right moment.
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